###begin article-title 0
SLC30A3 (ZnT3) Oligomerization by Dityrosine Bonds Regulates Its Subcellular Localization and Metal Transport Capacity
###end article-title 0
###begin p 1
Conceived and designed the experiments: GS VF. Performed the experiments: GS RH. Analyzed the data: GS JMFP RH VF. Contributed reagents/materials/analysis tools: JMFP VF. Wrote the paper: GS RH VF.
###end p 1
###begin p 2
Non-covalent and covalent homo-oligomerization of membrane proteins regulates their subcellular localization and function. Here, we described a novel oligomerization mechanism affecting solute carrier family 30 member 3/zinc transporter 3 (SLC30A3/ZnT3). Oligomerization was mediated by intermolecular covalent dityrosine bonds. Using mutagenized ZnT3 expressed in PC12 cells, we identified two critical tyrosine residues necessary for dityrosine-mediated ZnT3 oligomerization. ZnT3 carrying the Y372F mutation prevented ZnT3 oligomerization, decreased ZnT3 targeting to synaptic-like microvesicles (SLMVs), and decreased resistance to zinc toxicity. Strikingly, ZnT3 harboring the Y357F mutation behaved as a "gain-of-function" mutant as it displayed increased ZnT3 oligomerization, targeting to SLMVs, and increased resistance to zinc toxicity. Single and double tyrosine ZnT3 mutants indicate that the predominant dimeric species is formed between tyrosine 357 and 372. ZnT3 tyrosine dimerization was detected under normal conditions and it was enhanced by oxidative stress. Covalent species were also detected in other SLC30A zinc transporters localized in different subcellular compartments. These results indicate that covalent tyrosine dimerization of a SLC30A family member modulates its subcellular localization and zinc transport capacity. We propose that dityrosine-dependent membrane protein oligomerization may regulate the function of diverse membrane protein in normal and disease states.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Sitte1">[1]</xref>
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Chen1">[2]</xref>
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Pin1">[3]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Nufer1">[4]</xref>
###xml 648 651 648 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Robbins1">[5]</xref>
###xml 652 655 652 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Funami1">[7]</xref>
The quaternary structure of polytopic transmembrane proteins plays a critical role in defining their subcellular localization and, consequently, their function. For example, homo-dimerization regulates function and trafficking along the exocytic pathway of proteins as diverse as neurotransmitter transporters [1], cell adhesion molecules [2], G-coupled protein receptors [3] and membrane proteins in the ER-Golgi intermediate compartment [4]. Similarly, homo-oligomerization regulates the subcellular distribution and signaling capacity of receptors in the endocytic pathway. These include GABA, leukotriene B(4), and Toll/interleukin-1 receptors [5]-[7]. Critical to understand the effects that membrane protein homo-oligomerization exert on proteins is the definition of chemical interactions that hold membrane protein homo-oligomers. Identification of key residues and interfacial domains offers molecular targets to assess the functional role of chemical modifications involved in oligomerization and to predict homo-oligomerization in other membrane proteins. Here we present a new covalent homo-oligomerization mechanism in a member of the SLC30A family of zinc transporters that depends on redox-regulated covalent tyrosine dimerization.
###end p 4
###begin p 5
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Lemmon1">[8]</xref>
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Senes1">[9]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Chen1">[2]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Damian1">[10]</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-LaBella1">[11]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Edens1">[14]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Abdalla1">[15]</xref>
###xml 1031 1035 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-GarciaCastineiras1">[16]</xref>
###xml 1037 1041 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Giulivi1">[17]</xref>
###xml 1147 1151 1143 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Hensley1">[18]</xref>
###xml 1166 1170 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-GarciaCastineiras1">[16]</xref>
###xml 1258 1262 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Heinecke1">[19]</xref>
###xml 1348 1352 1340 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Krishnan1">[20]</xref>
###xml 1387 1391 1376 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Atwood1">[21]</xref>
Homo-oligomerization of membrane proteins occurs through non-covalent and covalent interactions, primarily within transmembrane domains. These interactions rely on glycine, leucine or cysteine residues. Among the non-covalent interactions, the most common involve GxxxG and GxxxG-like domains such as those found in glycophorin A, membrane transporters, and receptors [8], [9]. On the other hand, covalent oligomers are mostly mediated by disulfide bonds, like those in cell adhesion molecules and signaling receptors [2], [10]. A far less explored covalent oligomerization mechanism is that dependent on dityrosine bond formation. Dityrosine bonds are present in a limited group of structural proteins of the bacteria cell wall, invertebrate connective tissue, and in proteins of the vertebrate extracellular matrix [11]-[14]. Dityrosine bonds have been found in only one membrane protein, the angiotensin II AT2 receptor [15]. Dityrosine bond formation increases with aging, cellular stress, UV and gamma irradiation and disease [16], [17]. Increased levels of dityrosine modified proteins have been found in lesions such as atheromatous plates [18] and cataracts [16]; in pathological processes such as acute inflammation and systemic bacterial infection [19]. Recently dityrosine bonds have been associated with alpha-synuclein fibrillogenesis [20] and Abeta amyloid oligomerization [21]. In all these cases dityrosine bonds are thought to represent the cumulative damage of a protein or to regulate protein function by either decreasing the solubility of secreted proteins or increasing oligomer resilience to mechanical stress.
###end p 5
###begin p 6
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Palmiter1">[22]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Palmiter2">[23]</xref>
###xml 532 535 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Cole1">[24]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Kantheti1">[25]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar1">[26]</xref>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Dutzler1">[27]</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Palmiter3">[28]</xref>
###xml 1082 1086 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Suzuki2">[31]</xref>
###xml 1109 1113 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Murgia1">[32]</xref>
###xml 1216 1220 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Lu1">[33]</xref>
In this study we show that dityrosine bonds induced the oligomerization of the zinc transporter 3 (ZnT3), a member of the SLC30A family of zinc transporters. SLC30A family members reduce the cytoplasmatic concentrations of free zinc, either by mediating zinc efflux from the cell or by metal influx into intracellular compartments [22]. One of the most studied members of this family is the zinc transporter 3 (ZnT3). ZnT3 is expressed in brain where it transports zinc into synaptic vesicles [23]. Deficiencies in either ZnT3 (ZnT3-/-) [24] or in the machinery that regulates its subcellular localization [25], [26] severely deplete synaptic vesicles zinc content. Despite the relevance of this transporter to synaptic physiology, mechanisms regulating SLC30A members zinc transport activity remain poorly explored. This is due to a lack of structural information, which has been fundamental in the elucidation of regulatory mechanisms in other type of transporters, such as chloride channels [27]. The existence of ZnT oligomers has been suggested for ZnT1 and ZnT5, 6 and 7 [28]-[31] and recently for ZnT8 [32]. Moreover, the crystal structure of the bacterial SLC30A3 homolog, Yiip, revealed non-covalent dimers [33]. Here we show that in contrast with YiiP, ZnT3 forms covalent dimers mediated by intermolecular dityrosine bonds. Dityrosine bond formation occurs both spontaneously and induced by oxidative stress. Using site-directed mutagenesis we identified two critical tyrosines in the carboxy-terminal of ZnT3, one that prevented and one that increased dimerization. Our studies indicate that covalent tyrosine dimerization of a SLC30A family member modulates its subcellular localization and zinc transport capacity.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Antibodies
###end title 8
###begin p 9
###xml 886 890 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Guo1">[34]</xref>
###xml 970 974 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar1">[26]</xref>
###xml 999 1003 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Advani1">[35]</xref>
###xml 100 106 <span type="species:ncbi:9986">rabbit</span>
###xml 979 984 <span type="species:ncbi:10090">mouse</span>
The following antibodies were used for western blots: monoclonal anti transferrin receptor (H68.4), rabbit polyclonal anti SUMO2/3 and monoclonal anti SUMO1 were from Zymed Laboratories/Invitrogen (Carlsbad, CA). Ubiquitin monoclonal antibody was from Covance (Berkeley, CA). Anti SV2 (10H4) was from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA). Monoclonal anti synatophysin (Sy38) was from Chemicon International/Millipore, (Billerica, MA). Vamp2 (69.1) antibody was from Synaptic System (Goettingen, Germany). Polyclonal antibodies anti myc and HA were from Bethyl Laboratories, Inc (Montgomery, TX). Monoclonal anti-beta-actin (clone AC-15) was from Sigma (St Louis, MO). Polyclonal anti acetylated lysine was from Cell Signaling Technology, Inc. (Danvers, MA). Affinity purified polyclonal antibodies against PI4KIIalpha were described by Guo et al [34]. The following antibodies have been described previously: polyclonal anti ZnT3 [26] and mouse anti Vamp7-TI [35].
###end p 9
###begin title 10
Cell culture and drug treatments
###end title 10
###begin p 11
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar2">[36]</xref>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 462 463 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 464 465 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 727 728 713 714 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 729 730 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 764 765 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 767 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 241 246 <span type="species:ncbi:9796">Horse</span>
HEK293T cells were cultured in DMEM medium (Cellgro, Herndon, VA; 4.5 g/l glucose) containing 10% FBS (Hyclone, Lolgan, UT), 100 U/ml penicillin and 100 mg/ml streptomycin. PC12 cells were cultured in the same media, but with 5% FBS and 10% Horse serum. Transfected cells lines were maintained in media containing 0.2 mg/ml G418 as described previously [36]. Incubations with H2O2 or drugs were performed in RPMI medium at 37degreesC. Cells were incubated with H2O2 (Sigma) during 20 min to 1 h or MG-132 (Calbiochem) 10 microM during 12 hrs. Catalase 500 U/ml or the ROS scavengers N-acetyl cysteine (NAC, Sigma) 10 mM or EUK-134 50 microM (Cayman Chemical, Ann Arbor, MI) were added to cells 15 min prior to the addition of H2O2 10 mM and maintained during the H2O2 incubation. Myc-tagged zinc transporters ZnT4, ZnT5 and ZnT7 were expressed in HEK293T cells due to their low expression levels in PC12 cells.
###end p 11
###begin title 12
DNA constructs
###end title 12
###begin p 13
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-FalconPerez1">[37]</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
pcDNA3 vector (Invitrogen) containing the human amino terminal HA tag SUMO1, SUMO2 and SUMO3 constructs were obtain from Dr. John Hepler, Emory University. pCR3.1 vectors (Invitrogen) containing human zinc transporters ZnT1, ZnT3, ZnT4, ZnT5 and ZnT7-myc tagged in the carboxy-terminal domain were previously described [37].
###end p 13
###begin title 14
Site directed mutagenesis chimeras construction and DNA transfection
###end title 14
###begin p 15
###xml 157 162 <span type="species:ncbi:9606">human</span>
All mutants were created using the QuickChange mutagenesis kit (Stratagene, La Jolla, CA). Oligonucleotides for tyrosine to phenylalanine mutagenesis of the human ZnT3 were the following:
###end p 15
###begin p 16
###xml 20 60 20 60 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCCTTACGCTCACTTTCCATGTTGCCTCTGCAC-3&#8242;</named-content>
###xml 75 115 75 115 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGCAGAGGCAACATGGAAAGTGAGCGTAAGGGC-3&#8242;</named-content>
Y330F mutant: sense-5'-GCCCTTACGCTCACTTTCCATGTTGCCTCTGCAC-3' and antisense-5'-GTGCAGAGGCAACATGGAAAGTGAGCGTAAGGGC-3'.
###end p 16
###begin p 17
###xml 20 54 20 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGAAGCCTCATCCCGGCTCTTCTCCCG-3&#8242;</named-content>
###xml 69 104 69 104 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGGGAGAAGAGC CGGGATGAGGCTTCAG-3&#8242;</named-content>
Y357F mutant: sense-5'-CTGAAGCCTCATCCCGGCTCTTCTCCCG-3' and antisense-5'-CGGGAGAAGAGC CGGGATGAGGCTTCAG-3'.
###end p 17
###begin p 18
###xml 20 55 20 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGGTCGAGCAGTTTCAGCCG GAGATG-3&#8242;</named-content>
###xml 70 104 70 104 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATCTCCGGCTGAAACTGCTCGACCTGC-3&#8242;</named-content>
Y372F mutant: sense-5'-GCAGGTCGAGCAGTTTCAGCCG GAGATG-3' and antisense-5'-CATCTCCGGCTGAAACTGCTCGACCTGC-3'.
###end p 18
###begin p 19
###xml 66 71 <span type="species:ncbi:9606">human</span>
Oligonucleotides for tyrosine to phenylalanine mutagenesis of the human ZnT4 were the following:
###end p 19
###begin p 20
###xml 20 65 20 65 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; ATGAAAATAGAAGATGTATTTTCAGTCGAAGATTTAAAT-3&#8242;</named-content>
###xml 80 125 80 125 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTTAAATCTTCGACTGAAAATACATCTTCTATTTTCAT-3&#8242;</named-content>
Y355F mutant: sense-5' ATGAAAATAGAAGATGTATTTTCAGTCGAAGATTTAAAT-3' and antisense-5'-ATTTAAATCTTCGACTGAAAATACATCTTCTATTTTCAT-3'.
###end p 20
###begin p 21
###xml 20 65 20 65 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGAACACATTTGGCATGTTTAGATGTACTATTCAGCTT-3&#8242;</named-content>
###xml 80 125 80 125 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGCTGAATAGTACATCTAAACATGCCAAATGTGTTCAA-3&#8242;</named-content>
Y404F mutant: sense-5'-TTGAACACATTTGGCATGTTTAGATGTACTATTCAGCTT-3' and antisense-5'-AAGCTGAATAGTACATCTAAACATGCCAAATGTGTTCAA-3'.
###end p 21
###begin p 22
###xml 20 59 20 59 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTCAGCTTCAGAGTTTCAGGCAAGAAGTGGAC-3&#8242;</named-content>
###xml 74 113 74 113 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCCACTTCTTGCCTGAAACTCTGAAGCTGAAT-3&#8242;</named-content>
Y413F mutant: sense-5'-ATTCAGCTTCAGAGTTTCAGGCAAGAAGTGGAC-3' and antisense-5'-GTCCACTTCTTGCCTGAAACTCTGAAGCTGAAT-3'.
###end p 22
###begin p 23
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Human ZnT3-myc chimera (mhZnT3-myc) containing the amino terminal domain of mouse ZnT3 was constructed by adding an EcoR1 restriction site using the following oligonucleotides:
###end p 23
###begin p 24
###xml 32 64 32 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCATGGGAGCCTTCTCTGGCCACC-3&#8242;</named-content>
###xml 85 115 85 115 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAATTCGAAGCACACAGCGCAGGC-3&#8242;</named-content>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse N-Terminal (1-252): sense-5'-CACCATGGGAGCCTTCTCTGGCCACC-3' and antisense-EcoR1 5'-GAATTCGAAGCACACAGCGCAGGC-3'.
###end p 24
###begin p 25
###xml 29 58 29 58 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCGAATTCATGGCTGGGGAGG-3&#8242;</named-content>
###xml 77 116 77 116 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCACAGATCTTCTTCAGAAATAAGTTTTTGTTC-3&#8242;</named-content>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human (259-1167) sense EcoR1 5'-CACCGAATTCATGGCTGGGGAGG-3' and antisense myc 5'-TCACAGATCTTCTTCAGAAATAAGTTTTTGTTC-3'.
###end p 25
###begin p 26
The addition of the EcoR1 site create an amino acid change from V85 to E that was corrected by site directed mutagenesis using the following oligonucleotides:
###end p 26
###begin p 27
###xml 6 37 6 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTGTGTGCTTCGTATTCATGGCTGGGG</named-content>
###xml 52 83 52 83 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCCCAGCCATGAATACGAAGCACACAGC</named-content>
Sense-5'-GCTGTGTGCTTCGTATTCATGGCTGGGG and antisense-5'-CCCCAGCCATGAATACGAAGCACACAGC.
###end p 27
###begin p 28
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Mouse ZnT3-HA chimera (hmZnT3-HA) containing the amino terminal domain of human ZnT3 was constructed by adding an EcoR1 restriction site using the following oligonucleotides:
###end p 28
###begin p 29
###xml 32 55 32 55 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCATGGAGCCCTCTC-3&#8242;</named-content>
###xml 76 103 76 103 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAATTCAAAGCAAACGGCACA-3&#8242;</named-content>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human N-terminal (1-252): sense-5'-CACCATGGAGCCCTCTC-3' and antisense-EcoR1 5'-GAATTCAAAGCAAACGGCACA-3'.
###end p 29
###begin p 30
###xml 29 57 29 57 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCGAATTCATGGCCGGGGAG-3&#8242;</named-content>
###xml 75 105 75 105 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCAAGCGTAGTCTGGGACGTCGTA-3&#8242;</named-content>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse (259-1167) sense EcoR1 5'-CACCGAATTCATGGCCGGGGAG-3' and antisense HA 5'-TCAAGCGTAGTCTGGGACGTCGTA-3'. The amino acid E added by the creation of the EcoR1 site was corrected to V by site directed mutagenesis using the following oligonucleotides:
###end p 30
###begin p 31
###xml 6 41 6 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTGCCGTTTGCTTTGTATTCATGGCTGGGGAG</named-content>
###xml 56 94 56 94 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCCCCAGCCATGAATACAAAGCAAACGGCAC-3&#8242;</named-content>
Sense-5'-GTGCCGTTTGCTTTGTATTCATGGCTGGGGAG and antisense-5'-CTCCCCAGCCATGAATACAAAGCAAACGGCAC-3'.
###end p 31
###begin p 32
###xml 338 342 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar1">[26]</xref>
###xml 294 299 <span type="species:ncbi:10090">Mouse</span>
Oligonucleotides were from Sigma Genosys. All mutants and constructions were evaluated by DNA sequence. 1 microg of DNA was transfected in PC12 or HEK293 cells using 4 microl of Lipofectamin 2000 during 16 hrs. After 48 hrs, transfected cells were selected with 0.8 mg/ml G418 during one week. Mouse ZnT3-HA has been previously described [26].
###end p 32
###begin title 33
Cross-linking and immunoprecipitation
###end title 33
###begin p 34
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige1">[38]</xref>
###xml 369 370 369 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were washed twice in cold PBS plus CaCl2 and MgCl2 (PBS-CM) and incubated with 1 mM DSP (Pierce, Rockford, IL) or DMSO alone in PBS-CM for 2 hrs on ice as described [38]. The reaction was stopped by adding 25 mM Tris pH 7.4 for 15 min on ice and washing twice in PBS. Cells were lysed 30 min on ice in buffer A (150 mM NaCl, 10 mM HEPES, 1 mM EGTA and 0.1 mM MgCl2, pH 7.4), 0.5% Triton X-100 plus Completetrade mark anti-protease mixture (Roche Molecular Biochemical, Indianapolis, IN). Homogenates were clarified by sedimentation at 16,100xg for 10 minutes and supernatant immunoprecipitated using Dynal magnetic beads (Invitrogen, Carlsbad, CA) decorated with monoclonal antibodies against synaptophysin, or polyclonal antibodies against either myc or HA epitopes. After six washes with Buffer A 0.1% Triton X-100 for 5 min each, samples were loaded on 4-20% PAGE-SDS Criterion pre-cast gels (Bio-Rad, Carlsbad, CA) and analyzed by immunoblot. 1% to 2% of the initial homogenate was loaded as input.
###end p 34
###begin title 35
Sucrose sedimentation
###end title 35
###begin p 36
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige1">[38]</xref>
###xml 428 433 <span type="species:ncbi:9796">horse</span>
###xml 472 478 <span type="species:ncbi:9913">bovine</span>
###xml 510 522 <span type="species:ncbi:4120">sweet potato</span>
###xml 557 563 <span type="species:ncbi:9913">bovine</span>
Triton-X100 soluble supernatants from cells either treated with the crosslinker DSP or DMSO alone were separated in a 5% to 20% sucrose gradient prepared in buffer A plus 0.5% Triton X-100 during 13 hr at 187,000xg in a SW55 rotor [38]. Samples were collected from the bottom (250 microl/each) and analyzed by western blots. Gel filtration molecular weight markers (Sigma, saint Louis, MI) were used to calibrate the gradients: horse spleen apoferritin (443 kDa, 16.5 S), bovine serum albumin (66 kDa, 4.6 S), sweet potato beta-amylase (200 kDa, 9.4 S) and bovine erythrocytes carbonic anhydrase (29 kDa, 2.9 S).
###end p 36
###begin title 37
Cell fractionation
###end title 37
###begin p 38
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar2">[36]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-CliftOGrady1">[39]</xref>
###xml 780 784 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar2">[36]</xref>
PC12 cells differential fractionation and glycerol sedimentation were performed in intracellular buffer (38 mM potassium aspartate, 38 mM potassium glutamate, 38 mM potassium gluconate, 20 mM MOPS-KOH, pH 7.2, 5 mM reduced glutathione, 5 mM sodium carbonate, 2.5 mM magnesium sulfate, 2 mM EGTA) [36], [39]. Briefly, homogenate were sedimented 5 min at 1000xg to obtain a nuclear pellet (P1) and S1 supernatant that was sedimented at 27,000xg for 35 min to generate an S2 supernatant. S2 was loaded on the top of a 5% to 25% glycerol gradient. After 75 min at 218,000xg, samples were collected from the bottom. All gradient fractions were analyzed by immunoblot and immunoreactivity revealed by ECL. Immunoreactive bands were quantified using NIH Image 1.62 software as described [36].
###end p 38
###begin title 39
Zinquin staining and flow cytometry
###end title 39
###begin p 40
###xml 323 327 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar2">[36]</xref>
###xml 329 333 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar3">[40]</xref>
PC12 cells treated for 30 min with 25 microM ZnSO4 were washed and incubated with 25 microM zinquin during 1 hr at 37degreesC. Cells were washed twice at 4degreesC and resuspended in PBS. Fluorescence was determined using a MoFlo High-performance Cell Sorter from Dako Cytomation (Fort Collins, CO) as described previously [36], [40] or using a Synergy HT microplate reader (BioTek Instruments Inc. Vermont) with an excitation:emission filters of 340/30:460/40.
###end p 40
###begin title 41
Molecular modeling
###end title 41
###begin p 42
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Lu1">[33]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Harrison1">[41]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Harrison2">[42]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Bagossi1">[43]</xref>
###xml 1274 1278 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Harrison3">[44]</xref>
###xml 1684 1688 1684 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-DeLano1">[45]</xref>
###xml 593 597 <span type="species:ncbi:8233">tuna</span>
An initial molecular model for ZnT3 transporter was generated by the automated model server panther (). The homologous zinc transporter Yiip [33] (pdb id code 2QFI) was found by profile-profile alignment. Even though the alignment has only a 14% identity, the close functional similarity and the significant profile alignment score strongly suggested that there was a true homology. Critically, the residues involved with zinc binding are preserved between the two molecules in this alignment. The initial model was built using the AMMP program [41], [42] with the latest potential set (atoms.tuna). The ZnT3 protein dimer was built by applying the non-crystallographic symmetry to the model that relates to the two monomers of Yiip in the 2QFI crystal structure. The zinc atoms from the 2QFI structure were used in the modeling, and the protein dimer model was further energy minimized after being generated. The tyrosine dimer was implemented using the preAMMP system and parameterized with the semi-empirical charge generation in AMMP [43]. The pairs 357,372' and 357', 372 where inserted into the coordinates and the model generated via energy minimization of the non-tyrosine bonded protein dimer model. As in all AMMP calculations, the amortized fast multipole method [44] was used to avoid artifacts due to non-bonded and electrostatic cutoffs. The electrostatic fields were calculated with full exponential Debye-Huckel expansion of the ionization potential using the finite element solver in AMMP. Models were made for the other possible pairs of tyrosine dimers, but these did not alter the zinc binding sites. Images of the molecular models where generated with Pymol 0.99 [45].
###end p 42
###begin title 43
Cell viability
###end title 43
###begin p 44
PC12 cells expressing wt ZnT3 or ZnT3Y357F and ZnT3Y372F mutants were incubated during 24 hr with 200 microM to 250 microM ZnSO4. Cell viability was determined by trypan-blue exclusion using a Neubauer chamber. 100% viability was determined in the absence of zinc.
###end p 44
###begin title 45
Data Presentation
###end title 45
###begin p 46
All data are depicted as average+/-standard error of the mean
###end p 46
###begin title 47
Results
###end title 47
###begin title 48
Stabilization of the oligomeric states of ZnT3 by cross-linking
###end title 48
###begin p 49
###xml 39 55 39 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar1">[26]</xref>
###xml 39 55 <span type="species:ncbi:562">Escherichia coli</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
The similarity of sequence between the Escherichia coli zinc transporter Yiip and mammalian zinc transporters of the SCL30A family led us to hypothesize that dimer formation could be a common structural element, shared by SLC30A mammalian zinc transporters. In this study, we focused on the human zinc transporter 3 (ZnT3) as a model of transmembrane protein representative of the SLC30A family. We took advantage of PC12 cells because they express low levels of ZnT3, are easily transfected with tagged versions of this transporter, and ZnT3 endosome/synaptic-like microvesicles (SLMVs) subcellular localization is well characterized in these cells [26].
###end p 49
###begin p 50
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige1">[38]</xref>
###xml 681 688 681 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1A</xref>
We examined the formation of ZnT3 oligomeric species by co-immunoprecipitation of ZnT3 carrying different tags in their carboxy terminal domains. In order to facilitate detection of low affinity ZnT3 oligomers (dimers and/or high molecular weight species) we used dithiobis-succinimidylpropionate (DSP). DSP is a homobifunctional cell permeable cross-linker. This agent contains a disulfide bond, which allows complete cleavage of cross-linked products under reducing conditions [38]. PC12 cells co-expressing ZnT3-HA and ZnT3-myc, treated with and without DSP, were lysed and detergent soluble supernatants immunoprecipitated with magnetic beads coated with HA or myc antibodies (Fig. 1A). Immune complexes were analyzed by immunoblot with antibodies against myc or HA.
###end p 50
###begin title 51
Identification of ZnT3 oligomeric states.
###end title 51
###begin p 52
A) Triton soluble extracts of PC12 cells (450 microg) co-expressing ZnT3-HA and ZnT3-myc, treated with and without cross-linker (DSP), were immunoprecipitated with HA (lanes 1 and 2), myc (lanes 4 and 5) or synaptophysin (Sphysin, lanes 7 and 8) antibodies. Western blots were probed with myc, HA and synaptophysin and ZnT3 antibodies, respectively. Control immunoprecipitation with synaptophysin antibodies fail to isolate ZnT3. Input 10 microg. B) 1.5 mg of Triton-X100 soluble supernatant of ZnT3-myc expressing cells treated in the presence of vehicle (DMSO) or DSP (+DSP) were separated by sucrose sedimentation. Fractions were collected from the bottom and analyzed by immunoblot with myc antibodies. An 80 kDa and high molecular weight forms of ZnT3 were observed, together with the monomeric 40 kDa species.
###end p 52
###begin p 53
###xml 73 79 73 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig 1A</xref>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1A</xref>
###xml 279 286 279 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1A</xref>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1A</xref>
###xml 769 775 769 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig 1A</xref>
Immunoprecipitation with antibodies against HA isolated myc-tagged ZnT3 (Fig 1A, left panel). Conversely, immunoprecipitation with myc antibodies recovered the HA-tagged transporter (Fig. 1A middle panel). Interaction between the tagged ZnT3s was observed either in the absence (Fig. 1A, lanes 1 and 4) or presence (Fig. 1A, lanes 2 and 5) of cross-linker. Moreover, an 80 kDa band as well as high molecular weight bands containing both ZnT3-HA and ZnT3-myc were also observed. These bands are resistant to SDS and reducing agents consistent with covalently modified ZnT3. Synaptophysin (sphysin), an abundant polytopic synaptic vesicle protein in PC12 cells, was used as a control. No ZnT3 was observed in immunoprecipitations performed with synaptophysin antibodies (Fig 1A, right panel). Furthermore, synaptophysin was absent from HA and myc immunoprecipitations excluding spurious membrane protein binding to myc or HA-antibody decorated beads.
###end p 53
###begin p 54
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige1">[38]</xref>
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1B</xref>
###xml 515 522 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1B</xref>
###xml 524 528 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige1">[38]</xref>
###xml 679 689 667 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Figure 1 B</xref>
We next sought to investigate the molecular weight of ZnT3 oligomeric species by sedimentation on density gradients. Triton-X100 soluble supernatant of PC12 cells expressing ZnT3-myc, treated in the absence or presence of DSP, were separated by sucrose sedimentation [38], followed by reducing SDS-PAGE to revert cross-linking (Fig. 1B). The majority of the 40 kDa monomeric ZnT3 migrated at or above 4.6S, a sedimentation coefficient that exceeds the migration expected for a approximately40 kDa membrane protein (Fig. 1B) [38]. Moreover, the myc-tagged ZnT3 species of 80 kDa was also observed migrating at 4.6 S either in the absence or presence of cross-linker (see asterisk Figure 1 B, upper panel and lower panel). The 80 kDa band was resistant to reducing agents and SDS and increased in abundance in the presence of DSP. Moreover, new species of 160 and 240 kDa appeared sedimenting between 9.4 and 16.5S. These results show that ZnT3 forms covalent oligomeric structures, which are at least compatible with ZnT3 dimers and high molecular weight oligomers. Furthermore, a cell permeant cross-linking agent stabilizes these oligomeric species.
###end p 54
###begin title 55
ZnT3 80 kDa species is increased by oxidative stress
###end title 55
###begin p 56
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 329 330 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Saitoh1">[46]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Lee1">[47]</xref>
###xml 461 468 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig. 2A</xref>
###xml 488 489 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 491 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 547 554 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig. 2A</xref>
###xml 624 631 624 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig. 2A</xref>
###xml 1061 1067 1061 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig 2A</xref>
###xml 1178 1184 1178 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig 2A</xref>
###xml 1201 1202 1201 1202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1203 1204 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1512 1519 1504 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig. 2B</xref>
###xml 523 528 <span type="species:ncbi:9606">human</span>
The reduced SDS-PAGE migration of ZnT3 suggested that this transporter could form dimeric species. Alternatively, increased ZnT3 molecular weight might also occur by covalent post-translational modifications, such as sumoylation, multi mono-ubiquitylation and poly-ubiquitylation. To distinguish between these two hypotheses, H2O2 and the inhibitor of the proteasome MG-132, were used to increase general sumoylation [46] and ubiquitylation [47], respectively (Fig. 2A). Incubation with H2O2 increased the abundance of the human ZnT3 80 kDa form (Fig. 2A, lane 2), compared with control. In contrast, treatment with MG-132 (Fig. 2A, lane 3) induced the accumulation of high molecular weight ZnT3-myc complexes (>200 kDa). These complexes are probably formed in response to oxidative stress induce by MG-132, since they were not detected with antibodies against ubiquitin (data not shown). As expected, both treatments increased the abundance of sumoylated and ubiquitylated proteins, verified by immunoblot with antibodies against SUMO1, SUMO2/3 and ubiquitin (Fig 2A, lanes 4-12). Lysine acetylation, another post-translational modification, was unaffected in both conditions (Fig 2A, lanes 13-15). H2O2 or MG-132 treatments showed no effect on other synaptic vesicle membrane proteins, such as synaptophysin, synaptobrevin 2 (Vamp2), SV2 or phosphatidylinositol-4-kinase type II alpha (PI4KIIalpha), the late endosome/lysosome SNARE Vamp7 and PI4KIIalpha, or the endosomal marker transferrin receptor (Tfr-R) (Fig. 2B). These observations indicate that the increase in molecular weight of ZnT3, is not the result of unspecific aggregation of membrane proteins where ZnT3 resides.
###end p 56
###begin title 57
Covalently modified species of SLC30A family members are induced by oxidative stress.
###end title 57
###begin p 58
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 299 300 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 301 302 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 355 356 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 357 358 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 200 205 <span type="species:ncbi:9606">Human</span>
PC12 cells incubated without or with 100 mM H2O2 for 20 min or 10 microM MG132 for 12 hours were analyzed by immunoblot with antibodies against A) myc, SUMO1, SUMO2/3, ubiquitin or acetylated lysine. Human ZnT3 putative dimeric form (80 kDa band) and high molecular weight species were observed in H2O2 and MG-132 incubations, respectively. B) Effect of H2O2 and MG132 treatment in components of different intracellular compartments were analyzed by immunoblot with transferring receptor (Tfr-R, early/recycling endosomes), Vamp7-TI (late endosomes) and synaptophysin (Sphysin), SV2 and PI4KIIalpha (SLMVs) antibodies.
###end p 58
###begin title 59
The ZnT3 80 kDa species is a covalent dimer
###end title 59
###begin p 60
###xml 90 96 90 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g002">Fig 2A</xref>
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 423 430 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1</xref>
###xml 624 632 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1A</xref>
###xml 674 675 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 676 677 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 691 699 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1B</xref>
###xml 790 798 790 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1B</xref>
###xml 896 904 896 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1B</xref>
###xml 1028 1036 1028 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005896.s001">Fig. S1B</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
SUMO1 antibodies detected a band of 80 kDa in PC12 cells harboring myc tagged human ZnT3 (Fig 2A, lanes 4-6). Thus, we hypothesized that the increase in molecular weight induced by H2O2 was due to ZnT3 sumoylation. To test this hypothesis, we transfect HA-tag versions of SUMO1, SUMO2 or SUMO3 into PC12 cells expressing human ZnT3-myc. Protein sumoylation was induced by incubating cells in the presence of H2O2 or MG132 (Fig. S1). Immunoprecipitation of SUMO 1, 2 or 3 using HA antibodies isolated a wide range of sumoylated proteins and free SUMO, from control cells, but failed to isolate ZnT3-myc immunoreactive bands (Fig. S1A). Moreover, induction of sumoylation by H2O2 incubations (Fig. S1B), although it increased the amount of the 80 kDa ZnT3-myc species observed in the inputs (Fig. S1B, lanes 14-16), did not lead to ZnT3-myc immunoreactive material in SUMO-HA immunoprecipitations (Fig. S1B, lanes 4-12). No ZnT3 species were observed in HA immunoprecipitations of MG-132 treated cells expressing SUMO constructs (Fig. S1B, compare lanes 6, 9 and 12 with lane 3). Moreover, immunoprecipitations with myc antibodies and western blots with ubiquitin antibodies did not identify any ubiquitinated products (data not shown). These results exclude that the ZnT3 80 kDa or oligomeric species are sumoylated or ubiquitinated products and support the hypothesis that the 80 kDa species is a covalent ZnT3 dimer. Moreover, our findings indicate that the ZnT3 80 kDa covalent species is increased by oxidative stress.
###end p 60
###begin title 61
ZnT3 covalent dimer formation depends on tyrosines in its carboxy terminal domain
###end title 61
###begin p 62
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Malencik1">[48]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Malencik1">[48]</xref>
###xml 621 622 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 623 624 623 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1106 1107 1106 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1108 1109 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1111 1118 1111 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3A</xref>
###xml 1202 1209 1202 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3A</xref>
###xml 1278 1285 1278 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3A</xref>
###xml 1450 1452 1450 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 1459 1466 1459 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3B</xref>
###xml 1538 1547 1538 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1624 1625 1624 1625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1626 1627 1626 1627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1629 1636 1629 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 1685 1686 1685 1686 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1687 1688 1687 1688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1808 1817 1808 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1845 1854 1845 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1901 1910 1901 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1929 1936 1929 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3D</xref>
###xml 1958 1967 1958 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 2189 2196 2189 2196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 2272 2279 2272 2279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 2313 2322 2313 2322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 2329 2336 2329 2336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 2425 2432 2425 2432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 2479 2480 2479 2480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2481 2482 2481 2482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2484 2491 2484 2491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3C</xref>
###xml 2617 2626 2617 2626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 2634 2635 2634 2635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2636 2637 2636 2637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2791 2798 2791 2798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3A</xref>
###xml 2854 2860 2854 2860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig 3C</xref>
###xml 2974 2975 2974 2975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2976 2977 2976 2977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 650 655 <span type="species:ncbi:9606">Human</span>
###xml 1021 1026 <span type="species:ncbi:9606">human</span>
###xml 1559 1564 <span type="species:ncbi:9606">human</span>
###xml 1911 1916 <span type="species:ncbi:9606">human</span>
###xml 2073 2078 <span type="species:ncbi:9606">human</span>
One modification that could explain formation of covalent dimers regulated by oxidative stress is dityrosine bond formation [48]. Based on the chemistry of dityrosine synthesis, we selected two criteria to identify dityrosine bonds in the 80 kDa ZnT3 species [48]. First, dityrosine formation is induced by oxidative stress and second, is abrogated by tyrosine to phenylalanine mutation of critical residues. We previously showed a ZnT3 80 kDa band increased by oxidative stress, thus meeting the first requirement. We next tested whether tyrosine to phenylalanine mutations in ZnT3 tyrosine residues could abrogate the H2O2-induced dimer formation. Human ZnT3 possesses six tyrosine residues, two facing extracellular exposed domains, one in an intracellular loop, and three in the carboxy-terminal domain. We focused on the role of individual tyrosine residues present in the carboxy-terminal domain as candidates to mediate dimer formation (Y330, Y357 and Y372). Tyrosine to phenylalanine mutations were engineered in human ZnT3-myc and transiently transfected in PC12 cells, which were incubated with H2O2 (Fig. 3A). Mutation of tyrosine 372 shows a reduced amount of dimers compared with control (Fig. 3A, compare lanes 2 and 8). In contrast, Y357F increased dimerization (Fig. 3A, compare lanes 2 and 6). No differences in the response to oxidative stress, detected with SUMO2/3 antibodies, was observed between cell expressing Y372F mutant or wt ZnT3 (Fig. 3B). To further evaluate these differences permanent cells lines carrying wild type and mutant human ZnT3-myc were incubated with increasing concentrations of H2O2 (Fig. 3C). ZnT3 80 kDa species were quantified for each H2O2 concentration and expressed as a ratio of ZnT3 80 kDa species versus monomer. To determine differences with respect to wild type ZnT3, ratios obtained from wild type and tyrosine mutants were subtracted from the wild type human ZnT3 ratio (Fig. 3D, dimer ratio = 0 for wild type ZnT3). Much like in transiently transfected cells, two phenotypes were observed in cell lines expressing human ZnT3 mutant transporters. First, mutation of Y372F drastically reduced dimerization under control conditions (Fig. 3C, compare lane 19 with lane 1), as well as in response to oxidative stress (Fig. 3C lanes 20 to 24) when compared to wild type ZnT3 (Fig. 3C, lanes 2 to 6). In contrast, Y357F mutation increased dimerization both in the absence (Fig. 3C, compare lane 13 with lane 1) or presence of H2O2 (Fig. 3C, compare lanes 14 to 18 with lanes 2 to 6). The ZnT3 Y357F mutant increased ZnT3 80 kDa species 2 to 4 fold when compared to wild type after H2O2 incubation. No significant differences were observed in cells expressing the Y330F mutant irrespective of whether this mutant was expressed transiently (Fig. 3A, compare lanes 2 and 4) or in a stable PC12 cell line (Fig 3C, compare lanes 7-12 with 2-6). Immunoblot with SUMO2/3 antibodies showed that all cell lines were responsive to H2O2-induced oxidative stress.
###end p 62
###begin title 63
Covalent ZnT3 oligomeric species require tyrosine residues and free radicals for their formation.
###end title 63
###begin p 64
###xml 93 102 93 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 474 475 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 476 477 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 587 596 583 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 770 779 766 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 951 952 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 953 954 945 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1055 1056 1047 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1057 1058 1049 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Transiently transfected (A and B) or permanent (C) PC12 cell lines expressing human ZnT3-myc wild type or mutants in tyrosine 330, 357 or 372 were incubated without or with 10 mM (A and B) or increasing concentrations (C) of H2O2 during 1 hr in RPMI medium. 20 microg of total extracts were analyzed by immunoblot with the indicated antibodies. D and M denotes dimer and M monomer, respectively. D) Dimer formation was expressed as a ratio of dimer versus monomer for each H2O2 concentration as follow: (mutant ratio of dimer/monomer)- (wild type ratio of dimer/monomer). In the case of wild type ZnT3 the expected value is 0. Increase in ZnT3 dimer content is seen as positive values whereas a decrease corresponds to negative values. E) PC12 cells expressing ZnT3-myc wild type or tyrosine mutants ZnT3Y357F and ZnT3Y375F were pre-treated during 15 min without or with 10 mM N-acetyl cysteine (NAC) or 50 microM EUK138 before incubation with 10 mM H2O2 during 1 hr. F) PC12 cells expressing single and double mutants were treated with or without 10 mM H2O2 lysed and analyzed by western blot with myc antibodies.
###end p 64
###begin p 65
###xml 221 230 221 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 585 592 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3E</xref>
###xml 624 631 624 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3E</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
To further assess the role of oxidative stress on human ZnT3 tyrosine-dependent dimerization, we asked whether the formation of the ZnT3 80 kDa species could be prevented by pre-incubation with anti-oxidants. We compared wild type human ZnT3 and the Y330F and Y357F mutants. These mutants either do not affect the formation of the ZnT3 80 kDa species or increased its formation, respectively. The effects of H2O2 on dimer formation were completely abolished by catalase (data not shown) and significantly reduced by incubations with the free radical scavengers N-acetyl-cysteine (NAC, Fig. 3E lanes 3, 7 and 11) and EUK138 (Fig. 3E. lanes 4, 8 and 12) in all three cell lines. All together, these results demonstrate that the 80 kDa form of ZnT3 is a tyrosine dimer formed by a covalent bridge mediated mainly by tyrosine 372 in the carboxy terminal domain.
###end p 65
###begin p 66
###xml 496 502 496 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig 3F</xref>
###xml 887 893 887 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig 3F</xref>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
We further explored whether tyrosine residues in the cytosolic tail of human ZnT3 exhibited a dimerization hierarchy in response to oxidative stress. We specifically asked whether human ZnT3 harboring the Y372F mutation, which reduces the ZnT3 80 kDa species, was dominant over the Y357F mutation, which increases ZnT3 80 kDa species. Analysis of double mutants ZnT3Y357-372F showed reduced ZnT3 80 kDa species indicating that Y372 is critical and dominant in the formation of dityrosine dimers (Fig 3F, lanes 5-6). Moreover, these results indicate that the remaining Y330 present in ZnT3Y357-372F were less efficiently engaged in dimer formation with other Y330 residue. We next asked whether tyrosine dimers were formed between two Y372 residues. ZnT3 carrying only one tyrosine residue in position 372 by mutation of Y330-357 to F still displayed reduced ZnT3 80 kDa species content (Fig 3F, lanes 7-8). Thus, tyrosine dimers are not formed between two adjacent Y372 residues. These results argue for a model where the ZnT3 80 kDa predominant species is formed in trans between residues 372 and 357.
###end p 66
###begin title 67
Formation of ZnT3 tyrosine dimers regulates ZnT3 targeting to synaptic-like microvesicles (SLMV)
###end title 67
###begin p 68
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Malencik1">[48]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-LaBella1">[11]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-LaBella2">[13]</xref>
###xml 378 379 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 412 421 412 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g001">Fig. 1B</xref>
###xml 486 495 486 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 660 667 660 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g004">Fig. 4A</xref>
###xml 1014 1016 1014 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 496 501 <span type="species:ncbi:9606">human</span>
Dityrosine formation has been described mainly as a product of oxidative stress [48] and as a normal extracellular post-translational modification only in a limited group of secreted proteins, such as collagen and elastin [11], [13]. We used cross-linking and sucrose sedimentation to evaluate whether dimer formation in tyrosine mutants occurs spontaneously in the absence of H2O2 as we observed previously for wild type ZnT3 (Fig. 1B). Triton-X100 soluble extracts of PC12 expressing wild type human ZnT3-myc, ZnT3Y357F and ZnT3Y372F mutants treated with or without DSP were separated by sucrose sedimentation and western blots analyzed with myc antibodies (Fig. 4A). As we observed before, the ZnT3Y357F mutant showed a strong increase of dimeric forms even in the absence of DSP and the content of the ZnT3 80 kDa form was further increased by DSP treatment. On the contrary, Y372F mutant present a reduced dimerization that was modestly increased by the addition of DSP (1.3 folds compared with 2.2 folds for wt ZnT3). These results indicate that dimers are formed spontaneously and that DSP stabilizes ZnT3 oligomeric transient intermediaries.
###end p 68
###begin title 69
Tyrosine-dependent covalent oligomerization regulates ZnT3 targeting to PC12 SLMVs.
###end title 69
###begin p 70
###xml 401 410 401 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 486 493 486 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
A) Triton soluble extracts of PC12 cells treated with and without cross-linker, were separated in a 5-20% sucrose gradient. 19 fractions were collected from the bottom (fraction 1) and analyzed by immunoblot with myc antibodies. Either reduced or increased levels of dimerization were observed in ZnT3Y372F and ZnT3Y357F mutants in the presence DSP, respectively. B) PC12 stable cell lines expressing wild type ZnT3 and ZnT3Y357F and ZnT3Y372F mutants were fractionated as described in Methods. S2 (600 microg) supernatants were separated in glycerol gradients and ZnT3 distribution analyzed by immunoblot with myc antibodies. SLMVs peak, in the middle of the gradient. ZnT3 was quantified (C) and adjusted by expression levels in 10 microg of S1 (B, input). D) Total levels of ZnT3 tyrosine mutants in the gradients were compared with wild type ZnT3 (100%) in three independent experiments. ZnT3Y357F mutant: 165.3%+/-7.7%. ZnT3Y372F mutant: 65.5+/-14%.
###end p 70
###begin p 71
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar1">[26]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-NewellLitwa1">[49]</xref>
###xml 604 613 604 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 647 654 647 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g004">Fig. 4B</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Craige2">[50]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-CliftOGrady1">[39]</xref>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Grote1">[51]</xref>
###xml 953 957 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Schmidt1">[53]</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 614 619 <span type="species:ncbi:9606">human</span>
We hypothesized that if dimerization occurs spontaneously it could regulate human ZnT3 function either by affecting its subcellular localization and/or zinc transport activity. To test this hypothesis, we took advantage of ZnT3 mutants that either decrease or enhance the formation of the 80 kDa species. ZnT3 localized mainly in synaptic-like microvesicles (SLMV) and endosomes in PC12 cells [26], [49]. To investigate whether tyrosine dimerization affects ZnT3 vesicle targeting at steady state, S2 fractions containing SLMVs were resolved by glycerol velocity sedimentation from cell lines expressing wild type human ZnT3 and tyrosine mutants (Fig. 4B). SLMVs sediment in glycerol based on organelle size and they characteristically peak at the middle of glycerol gradients [50], [39] . In these gradients, changes in the targeting of membrane proteins to SLMVs is frequently seen as modification in the amount but not sedimentation of a marker [51]-[53].
###end p 71
###begin p 72
###xml 182 195 182 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g004">Fig. 4C and D</xref>
###xml 525 534 521 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 547 554 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g004">Fig. 4D</xref>
###xml 198 203 <span type="species:ncbi:9606">Human</span>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
ZnT3 targeting to SLMVs was determined in vesicles resolved in glycerol gradients. Results were quantified and normalized by the expression level in the initial fractionation input (Fig. 4C and D). Human ZnT3 carrying the Y357F mutation, which possesses an increased formation of ZnT3 80 kDa species, increased its targeting to SLMVs by 65%+/-7.76 (n = 3). In contrast, human ZnT3 harboring the Y372F mutation, which reduces the formation of the 80 kDa species, decreased its targeting by 35%+/-14.3% (n = 3) with respect to wild type human ZnT3 (Fig. 4D). These results indicate that tyrosine-mediated dimer formation regulates human ZnT3 targeting to SLMVs.
###end p 72
###begin title 73
Tyrosine dimerization regulates zinc transport capacity
###end title 73
###begin p 74
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar3">[40]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Zalewski1">[54]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Palmiter2">[23]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar2">[36]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar3">[40]</xref>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 464 469 <span type="species:ncbi:10090">mouse</span>
###xml 520 525 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:9606">Human</span>
ZnT3 increases vesicular zinc content when present in SLMVs [40]. Thus, we explored whether the changes in ZnT3 SLMV targeting due to a Y to F mutation correlated with modifications in zinc uptake. Organelle zinc stores were detected using zinquin, a zinc specific fluoroprobe [54]. As previously reported [23], [36], [40], vesicular zinc level was minimally affected by the over-expression of the mouse ZnT3 ortholog when compared with non-transfected cells (5A, mouse ZnT3, 1.1+/-0.04). In contrast, expression of the human ZnT3 increased zinc levels approximately2.5 fold (2.41+/-0.51, p<0.001). A significant increase in vesicular zinc stores was detected in cells expressing human versions of the intracellular zinc transporter ZnT4 (1.69+/-0.09, p = <0.001) and ZnT5 (2.27+/-0.2, p<0.001), but not ZnT1, a zinc transporter localized in the plasma membrane, that mediate zinc efflux to the extracellular milieu (1.12+/-0.26, p = 0.21). Human ZnT7 expression shows a modest 24% increase with respect to non-transfected cells (1.24+/-0.04, p<0.001).
###end p 74
###begin p 75
###xml 200 201 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 202 203 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5B</xref>
###xml 419 420 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 421 422 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5B</xref>
###xml 580 587 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5B</xref>
###xml 939 948 939 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1016 1023 1016 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5C</xref>
###xml 1094 1103 1094 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1346 1353 1342 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5C</xref>
###xml 1405 1406 1401 1402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1520 1527 1516 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5D</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
###xml 385 390 <span type="species:ncbi:10090">mouse</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 861 866 <span type="species:ncbi:9606">human</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
###xml 1104 1109 <span type="species:ncbi:9606">human</span>
###xml 1252 1257 <span type="species:ncbi:9606">human</span>
###xml 1580 1585 <span type="species:ncbi:9606">human</span>
The differences in zinc uptake by human and mouse ZnT3 orthologues prompted us to evaluate the capacity of mouse ZnT3 to form oligomers. PC12 cells expressing human or mouse ZnT3 were incubated with H2O2 or MG132, and the formation of oligomeric species compared by western blots under reducing conditions (Fig. 5B). Notably, a small proportion of the 80 kDa species was observed with mouse ZnT3-HA in the presence of H2O2 when compared with the human transporter (Fig. 5B, compare lane 5 with 2). Moreover, mouse ZnT3 seems to be insensitive to oligomerization induced by MG132 (Fig. 5B, compare lane 6 with 3). Based on these observations, we hypothesized that zinc transport is mediated by ZnT3 oligomeric species. A prediction that arises from this hypothesis is that the prevention of dimerization by tyrosine mutation should prevent zinc transport in the human ZnT3. Non-transfected PC12 cells (NT) and cells transfected with either wild type human ZnT3-myc or ZnT3 tyrosine mutants were stained with zinquin (Fig. 5C). Similar levels of vesicular zinc accumulation were observed in both wild type human ZnT3 (63.8+/-18.8) and the Y357F mutant capable of increased oligomer formation (53.7+/-3.8). On the contrary, the Y372F mutant that prevents human ZnT3 oligomer formation showed basal zinquin staining similar to non-transfected cells (Fig. 5C). Incubation with increasing concentrations of ZnSO4 further demonstrated the inability of the Y372F mutant to support zinc accumulation into vesicular compartments (Fig. 5D). These results are consistent with a model whereby human ZnT3 oligomers stabilized by dityrosine bonds are required for efficient zinc transport.
###end p 75
###begin title 76
Vesicular zinc storage is modified by mutants that affect tyrosine-mediated ZnT3 oligomer formation.
###end title 76
###begin p 77
###xml 90 97 90 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 613 614 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 615 616 601 602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 826 835 812 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 924 925 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 996 1005 976 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1134 1136 1108 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 1232 1233 1206 1207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1314 1335 1288 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1386 1388 1358 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 1441 1443 1407 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</italic>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 455 460 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:10090">mouse</span>
###xml 566 571 <span type="species:ncbi:9606">human</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
Vesicular zinc storage was measured with zinquin in permanent cells lines as described in Methods. A) PC12 cells non transfected (NT) and cells expressing mouse ZnT3HA or myc-tag human ZnT1, 3, 4, 5 and 7 were stained with zinquin and fluorescence analyzed by flow cytometry, results are express as mean+/-SD in three independent experiments for human ZnTs. hZnT1: 112+/-26.5, hZnT3: 241+/-51.3, hZnT4: 169+/-9.7, hZnT5 227+/-20.3, hZnT7: 124+/-4.19. For mouse ZnT3-HA results are mean+/-SD in one experiment by triplicate. B) Cell lines expressing mouse ZnT3-HA or human ZnT3-myc were incubated with or without H2O2 or MG132 and extract analyzed by immunoblot with myc and HA antibodies. C and D) Vesicular zinc storage was measured in a microplate reader. Non-transfected cells (NT) and cells expressing myc-tag human ZnT3 (wild type), ZnT3Y357F or ZnT3Y372F mutants were incubated with the indicated concentration of ZnSO4. Zinquin staining was expressed by microg of protein. NT: 22.4+/-5.4, wild type ZnT3: 63.8+/-18.8, Y357F: 53.7+/-3.8. Y372F: 17.4+/-4.3, n = 3 independent experiments. E) Permanent PC12 cell lines expressing wt ZnT3 and ZnT3Y357F or ZnT3Y372F mutants were incubated with the indicated concentration of ZnSO4 for 24 hr. Cell viability was measured by trypan-blue exclusion as described in Materials and Methods. Y357F mutant increased viability from 34+/-11.3 (wt) to 54.3+/-15 (p<0.05) at 225 microM and from 20.1 (wt) +/-5 to 29.9+/-4.3 (p<0.005) at 250 microM (n = 5 in two independent experiments). In contrast, loss-of-function Y372F mutant decreases cell viability to 4.5+/-0.48 (p<0.001) and 1.57+/-0.71 (p<0.0001), respectively (n = 6 in two independent experiments.
###end p 77
###begin p 78
###xml 258 267 258 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 382 389 382 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5E</xref>
###xml 583 592 583 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 786 795 786 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 802 809 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5E</xref>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
###xml 780 785 <span type="species:ncbi:9606">human</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
We hypothesized that the inability of the Y372F mutant to support zinc storage in vesicular compartments would affect cell viability when cells are challenged with toxic extracellular zinc concentrations. To test this hypothesis, PC12 cells lines expressing wild type human ZnT3 and tyrosine mutants were cultured in media containing increasing concentrations of ZnSO4 during 24 h (Fig. 5E). Cells expressing human ZnT3 carrying the Y372F mutation, which impairs ZnT3 dimerization, were sensitive to extracellular zinc. Cell viability was reduced when compared with cells expressing wild type human ZnT3. In contrast, cells expressing human ZnT3 carrying the Y357F mutant, which enhances ZnT3 dimerization, showed a modest but significant increase in cell viability compared with human wild type ZnT3 (Fig. 5E). These findings indicate that, although modest, a gain-of-function phenotype in human ZnT3 carrying the Y357F mutation becomes evident in cell challenged for a prolonged time with toxic zinc concentrations.
###end p 78
###begin title 79
Predicted structural changes induced by ZnT3 dityrosine bond oligomerization
###end title 79
###begin p 80
###xml 434 440 434 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Lu1">[33]</xref>
###xml 645 652 645 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6A</xref>
###xml 934 941 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6A</xref>
###xml 1242 1249 1242 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6A</xref>
###xml 1605 1612 1605 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6C</xref>
###xml 1728 1735 1728 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6D</xref>
###xml 1865 1872 1865 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6D</xref>
###xml 2221 2228 2221 2228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g006">Fig. 6B</xref>
###xml 405 410 <span type="species:ncbi:9606">human</span>
###xml 675 680 <span type="species:ncbi:9606">human</span>
Dityrosine bonded ZnT3 supports efficient zinc accumulation in intracellular organelles. This functional change predicts that ZnT3 oligomers containing trans dityrosine bridges between residues 357 and 372 should modify cytoplasmic determinants involved in zinc binding. We explored the structural changes induced by bridging tyrosines 357 and 372 in ZnT3 dimers using AMMP molecular modeling. We modeled human ZnT3 primary sequence (Fig. 6) using as a backbone the crystal structure coordinates of the bacterial ZnT3 homologue YiiP bound to zinc atoms [33]. ZnT3 dimers lacking dityrosine bonds closely resembled the crystal structure of YiiP (Fig. 6A, ZnT3). Zinc atoms in human ZnT3 bound to the cytosolic domain were exposed to water. However, ZnT3 dimers carrying a dityrosine bond between residues 357 and 372 acquired a closed conformation with zinc atoms bound to the cytosolic domain completely buried and away from solvent (Fig. 6A, ZnT3 diY357-372). The major conformational change involved in the 357-372 dityrosine dimer depended on the motion of the two cytoplasmic loops containing these two tyrosines. Since tyrosine 372 is on the C-terminus and therefore has few conformational restrictions, it moves more than tyrosine 357 (Fig. 6A). The modeling method was unlikely to produce major conformation changes as it used conjugate gradients, which is a local optimizer. The distribution of charges, as reflected in the electrostatic field calculated from the model in the presence of dielectric and counter ions showed few differences between the undimerized and dimerized tyrosine residues (Fig. 6C). The arrangement of zinc atoms was further explored by projecting cytosolic zinc atoms into the dityrosine bonds (Fig. 6D). Zinc atoms moved closer to the unexposed surface of the C-terminal domain of ZnT3 in dimers carrying 357-372 dityrosine bonds (Fig. 6D, compare yellow and green dots). Models made for other pairs of possible dityrosine states, such as 330-357 or 330-372 did not alter the zinc binding sites. The rearrangement seen with the 357-372 dityrosine bridge appears to alter the zinc binding sites and open up buried binding sites that are not present in molecules lacking dityrosine bonds (Fig. 6B). Zinc atoms not associated with this binding site are buried in both the tyrosine and dityrosine models. After formation of the dityrosine bond a complete set of well-formed zinc binding sites is generated. This set of sites spans the whole length of the molecule suggesting that dityrosine formation facilitates zinc transport by forming the shielded binding pathway for the C-terminal part of the transporter. This modeling supports the notion that ZnT3 domains involved in zinc binding undergo structural rearrangements in the presence of dityrosine bonds.
###end p 80
###begin title 81
ZnT3 homology modeling with the bacteria Yiip zinc transporter.
###end title 81
###begin p 82
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ZnT3 pairs or ZnT3 pairs bridged in trans by dityrosine bonds between tyrosine residues 357 and 372 were modeled using AMMP and visualized with Pymol. Modeling coordinates were obtained from the crystal structure of YiiP bound to zinc atoms. A) Depicts lateral views of ZnT3 pair surface models. Gray lines represent the middle of the lipid bilayer. Zinc atoms are depicted as green spheres. Tyrosines 357 and 372 are depicted either single or bonded in yellow. B) Depicts diaphanized surface models to highlight the position of zinc atoms (green spheres). C) Cytoplasmic views of the solvent exposed areas in the absence or presence of dityrosine bonding. Blue depicts the negative and red the positive potentials. D) Cytoplasmic view of zinc atoms arrangement in the cytosolic domain of ZnT3 pairs either in the absence of dityrosine bonds (green spheres) or in the presence of dityrosines (yellow spheres). Dityrosines bonds are represented as a reference point.
###end p 82
###begin title 83
Structural determinants defining dityrosine-dependent dimerization in SLC30A family members
###end title 83
###begin p 84
###xml 113 120 113 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7A</xref>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7B</xref>
###xml 368 369 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 475 482 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7B</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
ZnTs 1 to 8 possess C-terminal tyrosines that could mediate dityrosine bonding, as it is the case of human ZnT3 (Fig. 7A). To explore whether dityrosine bonds could be a common structural element in other SLC30A family members, we first examined whether myc-tagged versions of human ZnTs form covalent dimers in response to H2O2 (Fig. 7B). Similar to the human ZnT3, H2O2 induced covalently modified species in myc-tagged versions of human ZnT1, ZnT4 and ZnT5, but not ZnT7 (Fig. 7B).
###end p 84
###begin title 85
Dityrosine-dependent dimerization in SLC30A family members.
###end title 85
###begin p 86
###xml 631 632 631 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 633 634 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 704 713 704 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 807 808 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 809 810 809 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 407 412 <span type="species:ncbi:9606">human</span>
A) Carboxy terminal primary sequences of ZnTs 1-8 containing tyrosine residues are compared with ZnT3 tyrosines 330, 357 and 372. Negatively (E/D) and positively (R/K) charge residues are depicted in green and blue, respectively. ZnT3Y372 and ZnT4Y355 and 413 share a conserved YXXE sequence. NT denotes not tested. B) HEK293 cells were transiently transfected with plasmids encoding myc-tagged versions of human ZnT1, 3, 4, 5 and 7. Cell extracts were analyzed by immunoblot with myc antibodies. All zinc transporters tested, except ZnT7 showed covalently modified species resistant to SDS and reducing agents in the presence of H2O2. C) HEK293 cells transiently transfected with myc-tagged versions of wild type ZnT4 and Y355F, Y404F and Y413F mutants were incubated with the indicated concentrations of H2O2 during 30 min. Samples were analyzed by western blots with myc and SUMO2/3 antibodies. All three ZnT4 tyrosine mediated covalent tyrosine dimers.
###end p 86
###begin p 87
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7A</xref>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7A</xref>
###xml 602 603 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 604 605 604 605 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7B</xref>
###xml 859 868 859 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wild type</italic>
###xml 1014 1015 1014 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1016 1017 1016 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1053 1062 1053 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 1069 1076 1069 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7C</xref>
###xml 1136 1143 1136 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7C</xref>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">Human</span>
###xml 823 828 <span type="species:ncbi:9606">human</span>
Site directed mutagenesis and molecular modeling indicated that Y357-Y372 is the main bond involved in the dimerization of human ZnT3. Primary sequence analysis revealed that human ZnT3 residue Y372 is flanked by negatively charge amino acids (Fig. 7A). We searched whether other ZnT transporters possess Y residues surrounded by negatively charged residues. Human ZnT4 residues Y355 and Y413 are adjacent to a glutamic residue in position +3 from the tyrosine [YXXE] (Fig. 7A). In contrast, ZnT6, 7 and 8 contains tyrosines that lack negative residue in position +3. Interestingly, ZnT7 did not show H2O2-induced dimerization (Fig. 7B). To test whether at least one of the Y residues participating in dityrosine bonding needs to conform to the putative consensus YXXE, we performed site-directed mutagenesis of either the human ZnT4myc residue Y355 or Y413. Wild type and mutant ZnT4 constructs were expressed in HEK293 cells. Tyrosine to phenylalanine mutagenesis of either ZnT4 residues Y355 or Y413 decreased H2O2-induced dimerization compared with wild type ZnT4 (Fig. 7C). Similarly, mutagenesis of Y404F reduced dimer formation (Fig. 7C) indicating that ZnT4, like ZnT3, forms tyrosine dimers in which at least one of the Y residues abides to a putative YXXE consensus.
###end p 87
###begin p 88
###xml 634 641 634 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g008">Fig. 8A</xref>
###xml 712 713 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 727 740 727 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g008">Fig. 8B and C</xref>
###xml 784 785 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 786 787 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 842 849 842 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g008">Fig. 8B</xref>
###xml 974 975 974 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 976 977 976 977 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:10090">Mouse</span>
###xml 816 821 <span type="species:ncbi:9606">human</span>
###xml 869 874 <span type="species:ncbi:9606">human</span>
###xml 927 932 <span type="species:ncbi:10090">mouse</span>
Mouse and human ZnT3 dimer formation differs dramatically despite the fact that both ZnT3 orthologs are 86% identical. This led us to hypothesize that additional structural elements could modulate the ability of tyrosine residues to form covalent bonds. To test this hypothesis, we asked whether the amino terminal domain of human ZnT3 could confer sensitivity to oxidative stress-induce oligomerization to the mouse ZnT3 and vice verse. To this end, we constructed a mouse ZnT3-HA chimeras containing the amino terminal of human ZnT3 (hmZnT3-HA) and a human ZnT3-myc chimera containing the amino terminal of mouse ZnT3 (mhZnT3-myc) (Fig. 8A). Constructs were transfected in PC12 cells and cells incubated with H2O2 or MG-132 (Fig. 8B and C). Mouse ZnT3 amino terminal decreased the H2O2-induced dimerization of the human chimera mhZnT3-myc (Fig. 8B). In contrast, the human amino terminal domain increases dimerization of the mouse ZnT3 chimera (hmZnT3-HA) in response to H2O2 and oligomerization-induced by MG-132. Therefore, the amino terminal domain influences the ability of carboxy-terminal tyrosines to form covalent tyrosine bonds.
###end p 88
###begin title 89
ZnT3 amino terminal domain regulates tyrosine dimerization.
###end title 89
###begin p 90
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 209 218 209 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
###xml 294 299 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:9606">Human</span>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
A) ZnT3 mouse and human chimeras, hmZnT3-HA and mhZnT3-myc, in which amino terminal domains (1-75) were exchanged were incubated with or without H2O2 or MG132 (B and C). Oligomerization was then compared with wild type mouse and human ZnT3. B) The amino terminal domain of mouse ZnT3 decreases human transporter's oligomerization. C) Human amino terminal increases mouse ZnT3 tyrosine oligomerization.
###end p 90
###begin title 91
Discussion
###end title 91
###begin p 92
###xml 629 635 629 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g009">Fig. 9</xref>
###xml 736 737 736 737 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</underline>
###xml 752 753 752 753 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</underline>
###xml 771 772 771 772 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</underline>
In this study we demonstrate that tyrosine dimerization in a polytopic transmembrane protein, the zinc transporter 3 (SLC30A3/ZnT3), regulates the transporter's subcellular localization and its transport capacity. These functional changes correlate with structural rearrangements within the cytosolic domain of ZnT3 that favor the accessibility of zinc to metal binding sites, as suggested by molecular modeling studies. ZnT3 tyrosine dimer formation occurs spontaneously and it is induced by oxidative stress. Our conclusions are supported by phenotypes resulting from discrete tyrosine to phenylalanine mutants, illustrated in Fig. 9. Three tyrosines in the carboxy-terminal of ZnT3 were subject to site directed mutagenesis Y330 (TLTYHVA), Y357 (SRLYSRF) and Y372 (VEQYQPE). ZnT3 carrying the Y357 to phenylalanine mutation behaved as "gain-of-function" mutant, with increased dimer formation, enhanced ZnT3 targeting to SLMVs and cell protection to zinc toxicity. In contrast, mutation of Y372 induced a "loss-of-function" phenotype, with reduced dimerization, decrease SLMV targeting, impaired zinc transport into vesicle compartments and decrease protection to zinc toxicity.
###end p 92
###begin title 93
Model of ZnT3 dimer formation deduced from single and double tyrosine mutations.
###end title 93
###begin p 94
###xml 818 827 818 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
ZnT3 carboxy-terminal domains of two adjacent ZnT3 molecules are depicted by two vertical parallel black lines. Tyrosine residues and their position are illustrated in black circles. Lines connecting black circles depict covalent tyrosine bonds. Single and double mutant indicate that the predominant dimer is formed between Y372-Y357. Sorting to SLMVs and zinc transport was evaluated in the gain-of-function ZnT3Y357F and the loss-of-function ZnT3Y372F mutants. Increased dimerization of the ZnT3Y357F mutant increased its targeting to SLMVs without affecting its zinc transport capacity, measured by zinquin staining, but increase resistance to zinc toxicity. In contrast, mutation of Y372 decreases SLMV sorting, completely prevents zinc transport and increase cell toxicity to zinc. +/- denotes reduce respect to wild type and ND experiment not done.
###end p 94
###begin p 95
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Hastrup1">[55]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Bartholomaus1">[56]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Tao1">[57]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Malencik1">[48]</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-GarciaCastineiras1">[16]</xref>
###xml 805 809 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Giulivi1">[17]</xref>
###xml 881 885 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Hensley1">[18]</xref>
###xml 897 901 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-GarciaCastineiras1">[16]</xref>
###xml 952 956 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Heinecke1">[19]</xref>
###xml 1018 1022 1010 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Krishnan1">[20]</xref>
###xml 1057 1061 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Atwood1">[21]</xref>
###xml 1242 1246 1231 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Andersen1">[12]</xref>
###xml 1304 1308 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-LaBella2">[13]</xref>
###xml 1321 1325 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-LaBella1">[11]</xref>
Until now, dimerization of polytopic transmembrane proteins has been shown to occur by covalent and non-covalent interaction mainly through transmembrane domains. Covalent cysteine-based dimer formation has been extensively described for neurotransmitter transporters, such as the dopamine transporter, DAT [55] and the glycine transporter [56] as well as receptors [57]. The fact that dimeric forms of ZnT3 were resistant to reducing agents and increased in response to oxidative stress, lead us to investigate tyrosine-mediated dimerization. Since its discovery in 1959, dityrosine formation has been described as a post-translational modification related with cellular stress and disease [48]. Dityrosine modifications are produced in response to oxidative stress, aging [16], UV and gamma irradiation [17]. Increased levels of dityrosine have been found in atheromatous plates [18], cataracts [16], acute inflammation, systemic bacterial infection [19] and recently associated with alpha-synuclein fibrillogenesis [20] and Abeta amyloid oligomerization [21]. Di-tyrosine formation as a normal post-translational modification has been described only in a limited group of structural proteins of the bacteria cell wall and insect ligaments [12], and in proteins of the extracellular matrix as collagen [13] and elastin [11]. Here we show tyrosine dimerization in a polytopic transmembrane protein, mediated by tyrosine residues in the carboxy terminal domain. In contrast to the described damage connotation and structural roles of dityrosine bonds, ZnT3 tyrosine modification presents a new functional paradigm for dityrosine bonds as regulators of both subcellular localization and metal transport activity. This ZnT3 post-translational modification occurs spontaneously and it is regulated by oxidative stress.
###end p 95
###begin p 96
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 174 168 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3</xref>
###xml 264 270 264 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g009">Fig. 9</xref>
###xml 477 483 477 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g009">Fig. 9</xref>
###xml 654 660 654 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g009">Fig. 9</xref>
###xml 847 853 847 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g009">Fig. 9</xref>
###xml 853 862 853 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wild type</italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
PC12 cells expressing wild type human ZnT3 and tyrosine mutants incubated with H2O2 enabled us to identify tyrosine 372 as a major residue mediating ZnT3 dimerization (Fig. 3). ZnT3 dimers formed between Y330-Y330, Y357-Y357 or Y330-Y357 are likely less abundant (Fig. 9, dotted line in Y372F mutant). Moreover, double mutants Y330F, Y357F containing an intact Y372, shows reduce dimerization. This indicates that Y372 formed dimers with Y330 or Y357 but not Y372-Y372 dimers (Fig. 9, Y300, 357F). Additionally, double mutant Y357F, Y372F, expressing an intact Y330 also shows reduce dimerization indicating that dimers Y330-Y330 are poorly represented (Fig. 9 Y357, 372F). The fact that no detectable phenotype was observed in Y330 mutant indicates that dimerization between Y372 and Y357 is the predominant state of ZnT3 dimers at steady state (Fig. 9wild type).
###end p 96
###begin p 97
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 503 508 <span type="species:ncbi:9606">human</span>
Interestingly, the gain-of-function phenotype obtained by mutagenesis of tyrosine 357 in human ZnT3 indicates that tyrosine 357 might regulate the availability or proximity of Y330 and Y372 for dimer formation. Tyrosine residues involved in dityrosine bond formation or those adjacent could be subject to tyrosine post-translational modifications that could modulate dimerization and function of membrane proteins. For example NetPhos 2.0 (Technical University of Denmark) predicts that tyrosine 357 in human ZnT3, possesses a high probability for being a phosphate acceptor (0.633). Additionally, nitrosylation of tyrosines, a mofidication induced by oxidative stress, could modulate dityrosine bond formation of zinc transporters. These posttranslational events could affect tyrosine-dependent covalent dimerization, zinc transport, and cell response to metal challenges.
###end p 97
###begin p 98
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Palmiter2">[23]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005896-Salazar3">[40]</xref>
###xml 536 537 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 691 698 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5A</xref>
###xml 794 801 794 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7B</xref>
###xml 895 909 895 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5 C and D</xref>
###xml 1077 1091 1065 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5 C and D</xref>
###xml 1263 1270 1239 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g005">Fig. 5E</xref>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 311 316 <span type="species:ncbi:9606">human</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 496 501 <span type="species:ncbi:9606">Human</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
Zinc transport capacity is modulated by the dimeric state of ZnT3. Two lines of evidence lead us to conclude that dimers or higher oligomeric forms are the likely ZnT3 functional states. First, we observed a correlation between zinc transport into vesicle compartments and dimerization when comparing mouse and human ZnT3. The mouse ZnT3 fails to transport zinc into vesicle compartments as previously reported [23], [40]. In contrast, zinc transport capacity was 2.4 times higher in human ZnT3. Human ZnT3 forms dimers in response to H2O2, while the mouse transporter was almost insensitive. Moreover, we observed a significant zinquin staining in cells expressing ZnT4 and 5 but not ZnT7 (Fig. 5A). ZnT4 and ZnT5 form covalent oligomeric species in response to oxidative stress but not ZnT7 (Fig. 7B). Second, zinquin staining was lost in cells expressing the "loss-of-function" Y372F mutant (Fig. 5 C and D). Interestingly, zinc transport was not increased in the gain of function ZnT3Y357F mutant in assays that acutely assess zinc transport capacity (approximately1 hour; Fig. 5 C and D), but became evident as a small yet significant increase in assays that explored sustained zinc transport capacity required to evade zinc toxicity (approximately24 hours, Fig. 5E). In contrast, the loss-of-function ZnT3Y372F mutant increases cell death induced by zinc. Although, the mechanism is unknown, one possibility is that ZnT3Y372F may act as dominant negative mutant over endogenous zinc transporters leading to an unbalance of zinc homeostasis.
###end p 98
###begin p 99
###xml 520 527 520 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g007">Fig. 7A</xref>
We described tyrosine mediated dimerization in two member of the SLC30A family, ZnT3 and ZnT4. Considering the distribution of charged residues surrounding ZnT3 and ZnT4 tyrosines, we propose that a putative motif YXXE is at least one of the primary sequences involved in dityrosine bond formation in ZnT family members. Whether this motif could be expanded to YXX[D/E] or to YXE remains unknown, yet these primary structure arrangements would encompass ZnT2 and ZnT1 as candidates for dityrosine bonding, respectively (Fig. 7A). The generality of a YXXE motif, whether this motif is an obligated component in dityrosine bond formation, or whether there are multiple sequences that could mediate dityrosine bond formation requires further testing in other membrane proteins.
###end p 99
###begin p 100
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:9606">Human</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
###xml 426 431 <span type="species:ncbi:10090">mouse</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
Primary sequence determinants are not the only factors defining dityrosine-mediated dimerization. Differences in oligomerization and zinc transport capacity exhibited by the mouse and human ZnT3 orthologs pointed to a role of the amino terminal domain modulating dityrosine dimerization. Human ZnT3 amino terminal confers an enhanced capacity to respond to oxidative stress induced-oligomerization to mouse ZnT3. In contrast, mouse amino terminal confers an attenuated response to oxidative stress to the human transporter. These observations suggest species differences in biological mechanisms that depend on synaptic vesicle zinc content.
###end p 100
###begin p 101
In conclusion we identified tyrosine dimerization as a new redox-sensitive post-translational modification in the SLC30A family of zinc transporters. Moreover, we demonstrate that dimers/oligomers are likely a functional intermediary in ZnT3 zinc transport. This mechanism uncovers new avenues of zinc homeostasis regulation by oxidative stress shared by several members of the SLC30A family. Elucidation of such mechanism will help us to understand the role of zinc and zinc transporters in pathologic conditions such as neurodegenerative diseases and diabetes, in which zinc transporters are thought to be involved.
###end p 101
###begin title 102
Supporting Information
###end title 102
###begin p 103
###xml 626 633 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005896-g003">Fig. 3B</xref>
Covalently modified ZnT3 is not sumoylated. PC12 cells non-transfected (mock) or transfected with HA-tagged versions of SUMO1, SUMO2 or SUMO3 were incubated without (A) or with H2O2 or MG132 (B). Triton-X100 soluble supernatant (500 I(1/4)g) were immunoprecipitated with HA antibodies and immunocomplexes analyzed by immunoblot with antibodies against either the HA epitope present in recombinant SUMO or myc engineered in ZnT3. HA immunoprecipitation did not isolated ZnT3 dimers or high molecular weight species under any condition. Unspecific binding of ZnT3 to HA-coated beads was detected in untransfected mock extracts (Fig. 3B lane 3). Input 2%.
###end p 103
###begin p 104
(3.78 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
We are indebted to the Faundez lab members for their comments.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking.
###end article-title 108
###begin article-title 109
Structural elements necessary for oligomerization, trafficking, and cell sorting function of paraxial protocadherin.
###end article-title 109
###begin article-title 110
Allosteric functioning of dimeric class C G-protein-coupled receptors.
###end article-title 110
###begin article-title 111
ER export of ERGIC-53 is controlled by cooperation of targeting determinants in all three of its domains.
###end article-title 111
###begin article-title 112
GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer.
###end article-title 112
###begin article-title 113
Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein.
###end article-title 113
###begin article-title 114
Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.
###end article-title 114
###begin article-title 115
Sequence specificity in the dimerization of transmembrane alpha-helices.
###end article-title 115
###begin article-title 116
Folding of helical membrane proteins: the role of polar, GxxxG-like and proline motifs.
###end article-title 116
###begin article-title 117
Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.
###end article-title 117
###begin article-title 118
Evidence for dityrosine in elastin.
###end article-title 118
###begin article-title 119
The Cross-Links in Resilin Identified as Dityrosine and Trityrosine.
###end article-title 119
###begin article-title 120
Formation of insoluble gels and dityrosine by the action of peroxidase on soluble collagens.
###end article-title 120
###begin article-title 121
Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox.
###end article-title 121
###begin article-title 122
Dominant-negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration.
###end article-title 122
###begin article-title 123
###xml 39 44 <span type="species:ncbi:9606">human</span>
Detection of bityrosine in cataractous human lens protein.
###end article-title 123
###begin article-title 124
Dityrosine: a marker for oxidatively modified proteins and selective proteolysis.
###end article-title 124
###begin article-title 125
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.
###end article-title 125
###begin article-title 126
###xml 34 39 <span type="species:ncbi:9606">human</span>
Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress.
###end article-title 126
###begin article-title 127
Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
###end article-title 127
###begin article-title 128
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
###end article-title 128
###begin article-title 129
Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers.
###end article-title 129
###begin article-title 130
ZnT-3, a putative transporter of zinc into synaptic vesicles.
###end article-title 130
###begin article-title 131
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene.
###end article-title 131
###begin article-title 132
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles.
###end article-title 132
###begin article-title 133
The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation.
###end article-title 133
###begin article-title 134
Structural basis for ion conduction and gating in ClC chloride channels.
###end article-title 134
###begin article-title 135
Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc.
###end article-title 135
###begin article-title 136
Heteromeric protein complexes mediate zinc transport into the secretory pathway of eukaryotic cells.
###end article-title 136
###begin article-title 137
Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane.
###end article-title 137
###begin article-title 138
Two different zinc transport complexes of cation diffusion facilitator proteins localized in the secretory pathway operate to activate alkaline phosphatases in vertebrate cells.
###end article-title 138
###begin article-title 139
Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands.
###end article-title 139
###begin article-title 140
Structure of the zinc transporter YiiP.
###end article-title 140
###begin article-title 141
Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles.
###end article-title 141
###begin article-title 142
VAMP-7 mediates vesicular transport from endosomes to lysosomes.
###end article-title 142
###begin article-title 143
AP-3-dependent mechanisms control the targeting of a chloride channel (ClC-3) in neuronal and non-neuronal cells.
###end article-title 143
###begin article-title 144
Zinc transporter 2 (SLC30A2) can suppress the vesicular zinc defect of adaptor protein 3-depleted fibroblasts by promoting zinc accumulation in lysosomes.
###end article-title 144
###begin article-title 145
Phosphatidylinositol-4-kinase type II alpha contains an AP-3-sorting motif and a kinase domain that are both required for endosome traffic.
###end article-title 145
###begin article-title 146
Reconstitution of synaptic vesicle biogenesis from PC12 cell membranes.
###end article-title 146
###begin article-title 147
Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells.
###end article-title 147
###begin article-title 148
Analysis of six protein structures predicted by comparative modeling techniques.
###end article-title 148
###begin article-title 149
A self-assembling neural network for modeling polymers.
###end article-title 149
###begin article-title 150
"Improved Parameters for Generating Partial Charges: Correlation with Observed Dipole Moments".
###end article-title 150
###begin article-title 151
Amortized fast multipole algorithm for molecular modeling.
###end article-title 151
###begin article-title 152
Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.
###end article-title 152
###begin article-title 153
Proteasome inhibitors: valuable new tools for cell biologists.
###end article-title 153
###begin article-title 154
Dityrosine as a product of oxidative stress and fluorescent probe.
###end article-title 154
###begin article-title 155
Roles of BLOC1 and AP-3 complexes in cargo sorting to synaptic vesicles.
###end article-title 155
###begin article-title 156
Isolation of synaptic vesicles.
###end article-title 156
###begin article-title 157
A targeting signal in VAMP regulating transport to synaptic vesicles.
###end article-title 157
###begin article-title 158
ADP ribosylation factor 1 is required for synaptic vesicle budding in PC12 cells.
###end article-title 158
###begin article-title 159
Synaptic-like microvesicles of neuroendocrine cells originate from a novel compartment that is continuous with the plasma membrane and devoid of transferrin receptor.
###end article-title 159
###begin article-title 160
Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II).
###end article-title 160
###begin article-title 161
###xml 25 30 <span type="species:ncbi:9606">human</span>
Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.
###end article-title 161
###begin article-title 162
Glycine transporter dimers: evidence for occurrence in the plasma membrane.
###end article-title 162
###begin article-title 163
All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.
###end article-title 163
###begin p 164
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 164
###begin p 165
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a grant from the National Institutes of Health to V.F. (GM077569) and RWH (GM065762). Dr. Harrison is a GCC distinguished cancer scholar. Support for the modeling program development and hardware is from the Georgia Cancer Coalition and Georgia Research Alliance.
###end p 165

